Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey Alan Barnes, M.D.

Co-Author

This page shows the publications co-authored by Jeffrey Barnes and Jeremy Abramson.
Connection Strength

4.024
  1. Panobinostat in combination with rituximab in heavily pretreated diffuse large B-cell lymphoma: Results of a phase II study. Hematol Oncol. 2018 Oct; 36(4):633-637.
    View in: PubMed
    Score: 0.809
  2. Case 35-2013: A man with confusion and malaise. N Engl J Med. 2014 02 20; 370(8):784.
    View in: PubMed
    Score: 0.598
  3. R-CHOP: does one size fit all in diffuse large B cell lymphoma? Acta Haematol. 2014; 131(3):153-5.
    View in: PubMed
    Score: 0.586
  4. Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma. Haematologica. 2013 Apr; 98(4):615-9.
    View in: PubMed
    Score: 0.548
  5. Adult T-cell leukemia/lymphoma: complexities in diagnosis and novel treatment strategies. Oncology (Williston Park). 2009 Dec; 23(14):1267, 1270.
    View in: PubMed
    Score: 0.447
  6. Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma. Cancer. 2019 Nov 01; 125(21):3692-3698.
    View in: PubMed
    Score: 0.220
  7. Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma. Blood. 2019 08 15; 134(7):606-613.
    View in: PubMed
    Score: 0.216
  8. Case of the Massachusetts General Hospital: Case 35-2013: a 77-year-old man with confusion and malaise. N Engl J Med. 2013 Nov 14; 369(20):1946-57.
    View in: PubMed
    Score: 0.147
  9. Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease. Leuk Lymphoma. 2014 Mar; 55(3):538-43.
    View in: PubMed
    Score: 0.144
  10. Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 study. Leuk Lymphoma. 2013 Sep; 54(9):1915-20.
    View in: PubMed
    Score: 0.139
  11. Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. Cancer. 2010 Sep 15; 116(18):4283-90.
    View in: PubMed
    Score: 0.118
  12. Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells. Blood. 2019 05 16; 133(20):2212-2221.
    View in: PubMed
    Score: 0.053
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.